Norway – Laboratory, optical and precision equipments (excl. glasses) – Instruments for automation of nucleic acid extraction and pipetting for PCR set-up for Helse Bergen HF.

Justification for award: Sykehusinnkjøp HF, on behalf of the Laboratory Clinic at Helse Bergen HF, intends to enter into a procurement agreement for equipment for automation of nucleic acid extraction and pipetting to PCR set-ups. A framework agreement shall also be signed for instrument dependent consumables such as reagents, pipette tips, plates, etc. Two systems shall be procured, Chemagic Prime and Chemagic 360. Revvity Norway AS is the only supplier in the market who offers a system that the departments at the Laboratory Clinic need, and it is therefore assumed that the terms in the procurement regulations § 13-4 first section letter b no. 2 are fulfilled. Based on this, a direct procurement can be carried out. A description of the departments ́needs and a justification for why Revvity Norway AS is the only supplier who can fulfil the requirements for a new system in the departments. Biobank Haukeland and Cancer Genetics require a comprehensive and flexible system for automated extraction of nucleic acids. There is a need for two systems that shall be installed in two different floors at the Laboratory Clinic and these systems must be suitable for functioning as a mutual backup system for interruptions in operations or capacity challenges. The offered system must therefore be flexible as regards both sample material and sample volume, so that the solution covers the needs of both departments. It is also a requirement that the system that is delivered to Cancer Genetics can carry out automated sample distribution, normalisation and set up of PCR analyses. The manufacturer must also offer ready-validated kits and protocols. The offered system must be automated and it must be able to insulate nucleic acids from a wide range of sample types, including full blood, plasma, buffy coat, spit, FFPE, oral mucosa sample, as well as stabilised samples such as PAXgene and Streck tubes. The system shall be able to extract several nucleic acid types, including genomic DNA (gDNA), total RNA, circulating free DNA (cfDNA) and circulating free RNA (cfRNA). The system must ensure full traceability throughout the work flow, high reproducibility and minimise the risk of contamination through a closed and standardised process. Automated PCR set-ups shall also be possible, so that the entire work flow from nucleic acid insulation to analysis can be standardised and streamlined. Through its solution, Revvity offers two extraction units of the same method that can be placed at the two departments and function as backups for each other. This increases the total capacity, which is important for handling larger assignments within short delivery times, while maintaining efficient and stable operation. This provides increased operational security through the possibility of mutual back-up in connection with interruptions to operations or maintenance. In total this contributes to increased robustness, flexibility and capacity in daily operations. The system enables extraction from sample volumes from 10-18ml. This gives great flexibility in regard to sample material and area of use, reduces the need for manual handling and several processing steps, and contributes to reduced risk of material loss and sample handling errors. Revvity delivers fully optimised and validated protocols to all the extraction they offer, something that competitors cannot offer to the same extent. Access to validated protocols is important for the departments, as this reduces the time spent and provides predictable costs for the implementation of new kits and protocols. In addition it contributes to a more standardised and quality assured implementation, which reduces the risk of errors and ensures high quality in the analysis process. Revvity also has the advantage that there will be no additional programming costs when implementing new protocols. The departments currently use magnetic rod technology in the existing equipment and have good experience with this. Magnetic wand technology is considered necessary for maintaining established analysis quality, low risk of cross contamination and effective handling of large sample volumes. Revvity delivers this technology using the extraction principle based on the M-PVA magnetic rod, where the magnetic balls move instead of the liquid. The use of interchangeable magnetic wand heads (12, 24 and 96 channels) is given high flexibility in handling different sample volumes and varying number of samples. Option for sample volume up to 10 m. The magnetic pole heads are validated for use in the relevant applications and can be replaced by users. The departments have large space limitations and the Chemagic 360 ́s compact size enables flexible placement in the already limited existing area. Chemagic Prime has a width of 2,285 m which is within the available width of 2.5 m. Based on a completed market dialogue, direct dialogue with relevant tenderers and available documentation, alternative solutions are assessed against the contracting authority ́s needs. This includes flexibility in biological material and sample volume, optimised protocols, option for backup instrument, number of samples as well as limited available laboratory areas, divided between different floors. We consider that no supplier other than Revvity Norway AS can offer a comprehensive solution that fulfils the needs of Biobank Haukeland and the Section for Cancer Genetics. Oppdragsgiver: SYKEHUSINNKJØP HF Type: veat Kilde: TED Europa (via DOFFIN)

Oppdrags-detaljer

buyer:

SYKEHUSINNKJØP HF

source:

TED Europa

cpvCodes:

38000000

noticeType:

veat

referenceNumber:

766795-2026